Diagnostic procedures in the follow-up of patients affected by men type 2

Tumori

Volumn 89, Issue 5, 2003, Pages 563-565

  Seregni, Ettore ^a   Pallotti, Federica ^a   Mattavelli, Franco ^a   Ferrari, Leonardo ^a   Martinetti, Antonia ^a   Aliberti, Gianluca ^a   Villano, Carlo ^a   Castellani, Maria Rita ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Hyperparathyroidism; Medullary thyroid carcinoma (MTC); MEN 2 syndromes; Pheochromocytoma

Indexed keywords

PROTEIN RET;

DIAGNOSTIC PROCEDURE; FAMILIAL CANCER; FOLLOW UP; GENE MUTATION; GERM LINE; HUMAN; HYPERPARATHYROIDISM; MONITORING; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PROTO ONCOGENE; REVIEW; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

EID: 0346564118     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900524     Document Type: Review

References (19)

1. Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Aiello A, Pansini G, Trasforini-Gi, Ciro degli Uberti E: RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. Surgery, 131: 373-381, 2002.
2. Huang SC, Torres-Cruz J, Pack SD, Koch CA, Vortmeyer AO, Mannan P, Lubensky IA, Gagel RF, Zhuang Z: Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma. J Clin Endocrinol Metab, 88: 459-463, 2003.
3. Klein I, Esik O, Homolya V, Szeri F, Varadi A: Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. J Endocrinol, 170: 661-666, 2001.
4. Lemos MC, Carrilho F, Rodrigues FJ, Santos P, Carvalheiro M, Ruas MA, Regateiro FJ: Early onset of medullary thyroid carcinoma in kindred with multiple endocrine neoplasia type IIA associated with cutaneous lichen amyloidosis. Endocr Pract, 8: 19-22, 2002.
5. Sanso GE, Domene HM, Garcia Rudaz MC, Pusiol E, de Mondino AK, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M: Very early detection of RET protooncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children. Cancer, 94: 323-330, 2002.
6. Cohen MS, Phay JE, Albison C, De Benedetti MK, Skinner MA, Lairmore TC, Doherty GM, Balfe DM, Wells SA, Moley JF: Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg, 235: 648-655, 2002.
7. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devoix B, Falchetti A, Gheri RG, Libroia A, Lips CJM, Lombardi G, Mannelli M, Pacini F, Ponder BAJ, Raue F, Skogsein B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA, Marx SJ: Guidelines for diagnosis and therapy of MEN-type 1 and type 2. J Clin Endocrinol Metab, 86: 5658-5671, 2001.
8. Uwaifo GI, Remaley AT, Stene M, Reynolds JC, Yen PM, Snider RH, Becker KL, Sarlis NJ: A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Invest, 24: 361-369, 2001.
9. Seregni E, Ferrari L, Stivanello M, Dogliotti L: Laboratory tests for neuroendocrine tumours. Q J Nucl Med, 44: 22-41, 2000.
10. Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, Lange H, Bredow J, Korber C, Grunwald F: Fluorine-18-fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med, 28: 1671-1676, 2001.
11. Lenders JWM, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G: Biochemical diagnosis of pheochromocytoma. JAMA, 287: 1427-1434, 2002.
12. Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G: Utilility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab, 87: 1955-1960, 2002.
13. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr: A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab, 88: 553-558, 2003.
14. Kjaer A, Petersen CL: Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomography. Clin Nucl Med, 27: 868-870, 2002.
15. Kraimps JL, Denizot A, Carnaille B, Henry JF, Proye C, Bacourt F, Sarfati E, Dupond JL, Maes B, Travagli JP, Boneu A, Roger P, Houdent C, Barbier J, Modigliani E: Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. World J Surg, 20: 808-812, 1996.
16. Marx SJ, Simonds EF, Agarwal SK, Burns AL, Wrinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HRJ, Chen CC, Chang R, Chandrasekharappa SC, Collins FS: Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res, 17: 37-43, 2002.
17. Goldestein RE, Billheimer D, Martin WH, Richards K: SestaMIBI scanning invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg, 237: 722-731, 2003.
18. Sekiyama K, Akakura K, Mikami K, Mizoguchi K, Tobe Ti Nakano K, Numata T, Konno A: Usefulness of diagnostic imaging in primary hyperparathyroidism. Int J Urol, 10: 7-11, 2003.
19. Crippa F, Alessi A, Gerali A, Bombardieri E: FDG-PET in thyroid cancer. Tumori, 89: 540-543, 2003.